Market Research Report
North America Sleep Apnea Therapeutics and Diagnostics Market Forecast 2021-2028
|Published by||Inkwood Research||Product code||1018668|
|Published||Content info||164 Pages
Delivery time: 2-3 business days
|North America Sleep Apnea Therapeutics and Diagnostics Market Forecast 2021-2028|
|Published: July 19, 2021||Content info: 164 Pages||
The North America sleep apnea therapeutics and diagnostics market growth is estimated to progress at a CAGR of 6.10% during the forecast period, 2021-2028. The growing demand for portable sleep apnea devices and technological advancements in the sleep apnea devices and platforms propel market growth.
Canada and the United States are assessed for the North America sleep apnea therapeutics and diagnostics market growth analysis. In Canada, the sleep apnea prevalence is moderate. The market growth is attributed to the growing demand for PAP devices. The emerging sleep apnea devices and platforms industry is primarily dependent on conventional sleep apnea devices. However, the unequal access to treatment, partial reimbursement, and lack of funds for research, restrict the technology integration in the sleep apnea devices. Also, the adoption of remote patient assessment devices is hindered due to the exclusion of home sleep testing from reimbursement.
Furthermore, the pandemic impact has negatively impacted the clinical diagnosis of sleep apnea. As per the statement by the Canadian Thoracic Society published on April 2020, clinical visits have been discontinued, available only in the case of an emergency.
Some of the prominent market players include: Invacare Corporation, Cadwell Industries Inc, Smiths Medical Inc, Itamar Medical Ltd, ResMed Inc, etc.